Journal
Molecular imaging and biology
Publication Date
8-1-2024
Volume
26
Issue
4
First Page
738
Last Page
752
Document Type
Open Access Publication
DOI
10.1007/s11307-024-01901-5
Rights and Permissions
Zheleznyak, A., Tang, R., Duncan, K. et al. Development of New CD38 Targeted Peptides for Cancer Imaging. Mol Imaging Biol 26, 738–752 (2024). https://doi.org/10.1007/s11307-024-01901-5 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Zheleznyak, Alexander; Tang, Rui; Duncan, Kathleen; Manion, Brad; Liang, Kexian; Xu, Baogang; Vanover, Alexander; Ghai, Anchal; Prior, Julie; Lees, Stephen; Achilefu, Samuel; Kelly, Kimberly; and Shokeen, Monica, "Development of new CD38 targeted peptides for cancer imaging." Molecular imaging and biology. 26, 4. 738 - 752. (2024).
https://digitalcommons.wustl.edu/oa_4/4381
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
